| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/24/2004 | CN1484524A 5-HT IA veceptor subtype agonist |
| 03/24/2004 | CN1484523A Pharmaceutical composition containing citalopram |
| 03/24/2004 | CN1483782A Adhesive |
| 03/24/2004 | CN1483729A Method for preparing 5-phenoxymethoy 1-2-ephedroxane |
| 03/24/2004 | CN1483467A Ginseng pearl drpo pills and preparation process thereof |
| 03/24/2004 | CN1483446A Traditional Chinese medicine for treating neurosism, extracting process, formation process and use thereof |
| 03/24/2004 | CN1483443A Medicine for treating prospoalgia |
| 03/24/2004 | CN1483430A Health care medicinal composition for improving sleeping and preparation preocess thereof |
| 03/24/2004 | CN1483419A Medicine for treating epilepsis |
| 03/24/2004 | CN1483417A Compound granular medicine for giving up drug taking |
| 03/24/2004 | CN1483410A Medicinal complsition containing vitamin B 1, preparation process and use thereof |
| 03/24/2004 | CN1483409A Buspirong hydrochloride transdemal absorption preparation |
| 03/24/2004 | CN1483407A Medicinal composition containing rotundine for anayesia and giving up drug-taking |
| 03/24/2004 | CN1142931C 4-tetrahydropyridylpyrimidine derivatives |
| 03/24/2004 | CN1142926C Method for preparing citralopram |
| 03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
| 03/24/2004 | CN1142916C Dopamine D1 receptor agonist compounds |
| 03/24/2004 | CN1142913C Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/24/2004 | CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof |
| 03/24/2004 | CN1142780C Pharmaceutical compositions |
| 03/24/2004 | CN1142773C Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof |
| 03/23/2004 | US6710179 Compounds with analgesic effect |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710087 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710073 Drugs that induce long term potentiation (ltp) and enhance cognitive function in mammals |
| 03/23/2004 | US6710071 Such as ((3-4-(difluoro(phenyl)methyl)phenoxyl-3-phenylpropyl)methylamino)acetic acid; for the enhancement of cognition and the treatment of scizophrenia and other psychoses |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710060 4-hydroxypiperidine derivatives having antiarrhythmic activity |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710044 Technical field |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/23/2004 | US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/23/2004 | US6710041 Pyrrolo[2,1-B][3,1] benzothiazepines and their use for the preparation of medicaments with antipsychotic activity |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709651 Administering peptidase; substance p antagonist; central nervous system disorders |
| 03/23/2004 | US6709595 Solvent extraction at supercritical pressure |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2168432C Piperazine compounds used in therapy |
| 03/23/2004 | CA2101575C New cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022573A2 Adenosine a3 receptor agonists |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022564A2 Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate |
| 03/18/2004 | WO2004022560A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/18/2004 | WO2004022559A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/18/2004 | WO2004022558A2 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022556A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022550A1 Compound for treatment of anxiety and methods of preparation and use thereof |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022540A2 Pyridazinone and pyridone derivatives as adenosine antagonists |
| 03/18/2004 | WO2004022539A1 Naphthyl ether compounds and their use |
| 03/18/2004 | WO2004022536A1 New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022075A1 Treatment of neurological disorders by dsrna adminitration |
| 03/18/2004 | WO2004022043A1 Use of a sri and vitamin b6 for the treatment of neurological and mental disorders |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/18/2004 | WO2003099289A3 Compositions and their uses for alleviating pain |
| 03/18/2004 | WO2003099265A3 Pharmaceutical active substance combination and the use thereof |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003094830A3 Novel azacyclic ethynyl derivatives |
| 03/18/2004 | WO2003092684A8 TIME-RESOLVED FLUORESCENCE ASSAY FOR THE DETECTION OF MULTIMERIC FORMS OF A-β[BETA] OR OTHER AGGREGATING POLYPEPTIDES |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003072734A3 Bipolar trans carotenoid salts and their uses |
| 03/18/2004 | WO2003072111A3 Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003070731A3 Azabicyclic compounds for the treatment of disease |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003047500A3 Vaccine and method for treatment of motor neurone diseases |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003041701A3 Preparation for improving the action of receptors |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | WO2003026563A3 Conjugated anti-psychotic drugs and uses thereof |
| 03/18/2004 | US20040054213 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2004 | US20040054193 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 03/18/2004 | US20040054187 Therapeutic ureas |
| 03/18/2004 | US20040054182 Antiinflammatory agents; rheumatic diseases; antiallergens; skin disorders; anticancer agents; antidiabetic agents |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
| 03/18/2004 | US20040054177 Novel benzimidazole derivatives |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |